|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-4-16
|
|
pubmed:abstractText |
A previous phase II study of doxifluridine in non-elderly patients with advanced gastric cancer demonstrated a favorable survival with mild toxicity, despite a low response rate. The objectives of this study were to evaluate efficacy and feasibility of this agent for elderly patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
90-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11956303-Aged,
pubmed-meshheading:11956303-Aged, 80 and over,
pubmed-meshheading:11956303-Antimetabolites, Antineoplastic,
pubmed-meshheading:11956303-Drug Administration Schedule,
pubmed-meshheading:11956303-Female,
pubmed-meshheading:11956303-Floxuridine,
pubmed-meshheading:11956303-Humans,
pubmed-meshheading:11956303-Male,
pubmed-meshheading:11956303-Registries,
pubmed-meshheading:11956303-Stomach Neoplasms,
pubmed-meshheading:11956303-Survival Rate
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG 9410).
|
|
pubmed:affiliation |
Department of Internal Medicine, Mitoyo General Hospital, Mitoyo-gun, Kagawa, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
